Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes – ANNALS OF ONCOLOGY

Olmos, D; Lorente, D; Alameda, D; Cattrini, C; Romero-Laorden, N; Lozano, R; Lopez-Casas, PP; Jambrina, A; Capone, C; Vanden Broecke, AM; Trevisan, M; Van Sanden, S; Juergens, A; Herrera-Imbroda, B; Castro, E – 2024 – 10.1016/j.annonc.2024.01.011

Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial – EUROPEAN UROLOGY

Garcia-Ruiz, A; Macarro, C; Zacchi, F; Morales-Barrera, R; Grussu, F; Casanova-Salas, I; Sanguedolce, F; Gonzalez, M; Cresta-Morgado, P; de Albert, M; Garcia-Bennett, J; Marmolejo, D; Planas, J; Roche, S; Mast, R; Zatse, C; Piulats, JM; Herrera-Imbroda, B; Regis, L;...

A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532) – EUROPEAN UROLOGY ONCOLOGY

Tombal, BF; Gomez-Veiga, F; Gomez-Ferrer, A; López-Campos, F; Ost, P; Roumeguere, TA; Herrera-Imbroda, B; D’Hondt, LA; Quivrin, M; Gontero, P; Villà, S; Khaled, H; Fournier, B; Musoro, J; Krzystyniak, J; Pretzenbacher, Y; Loriot, Y – 2024 –...